2,3,5-Triphenyl-2H-tetrazolium kiloraidi Cas:298-96-4 98% Paa-funfun/pale ofeefee crystalline powder
Nọmba katalogi | XD90154 |
Orukọ ọja | 2,3,5-Triphenyl-2H-tetrazolium kiloraidi |
CAS | 298-96-4 |
Ilana molikula | C19H15N4 · Cl |
Òṣuwọn Molikula | 334.80 |
Awọn alaye ipamọ | 2 si 8 °C |
Ti irẹpọ Owo idiyele koodu | 29339980 |
Ọja Specification
Ifarahan | Pa-funfun/ bia ofeefee kirisita lulú |
Asay | Min.98% |
Ojuami Iyo | 235 - 245 Deg C |
Isonu lori Gbigbe | <3.0% |
Omi akoonu | 0.5% ti o pọju |
Aloku lori Iginisonu | O pọju.0.5% |
Solubility ni EtoH | Kọja |
Solubility ni Ethanol | Ko o ati pipe |
Lati ṣe iwadii ipa anfani ti apapo ti butyrate, Lactobacillus casei, ati L-carnitine ni awoṣe colitis eku.A pin awọn eku si awọn ẹgbẹ meje.Awọn ẹgbẹ mẹrin gba butyrate oral, L-carnitine, Lactobacillus casei ati apapo awọn aṣoju mẹta fun awọn ọjọ 10 itẹlera.Awọn ẹgbẹ to ku pẹlu odi ati awọn iṣakoso rere ati ẹgbẹ aṣiwere kan.Macroscopic, awọn idanwo histopathological, ati awọn ami-ara bi tumor necrosis factor-alpha (TNF-α) ati interlukin-1β (IL-1β), myeloperoxidase (MPO), thiobarbituric acid ifaseyin nkan (TBARS), ati ferric dinku agbara ti pilasima (FRAP). ) ni a pinnu ni oluṣafihan. Itọju ailera ti o ṣe afihan ipa ti o ni anfani ti o pọju ni idinku ti colitis akawe si awọn iṣakoso.Awọn iyipada lapapọ ni idinku ti TNF-α (114.66 ± 18.26 vs 171.78 ± 9.48 pg/mg protein, P <0.05), IL-1β (24.9 ± 1.07 vs 33.06 ± 2.16 pg/mg protein, P), <2.0.0. ± 0.03 vs 0.49 ± 0.04 μg / mg amuaradagba, P <0.01), MPO (15.32 ± 0.4 vs 27.24 ± 3.84 U / mg amuaradagba, P <0.05), ati igbega ti FRAP (23.46 ± 5.2 ± 1.2 μmo 1.22 μmo . , P <0.05) ṣe atilẹyin ààyò ti itọju ailera ni afiwe si awọn iṣakoso.Botilẹjẹpe awọn monotherapies tun munadoko ni ilọsiwaju ti awọn ami ami colitis, itọju apapọ dara julọ ni ilọsiwaju ti awọn ami aapọn aapọn colon oxidative pẹlu FRAP, TBARS, ati MPO.Apapọ ti o wa bayi jẹ idapọ ti o dara ni iṣakoso ti colitis esiperimenta ati pe o yẹ ki o ṣe idanwo ni awọn isẹgun eto.